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Objective: To investigate the effect of Thymus vulgaris (T. vulgaris) on learning and
memory functions in scopolamine-induced memory deﬁcit in rats. Memory enhancing
activity in scopolamine-induced amnesic rats was investigated by assessing the Morris
water maze and passive avoidance paradigm.
Methods: A total of 42 male Wistar rats were divided into 6 equal groups as follow:
control group: received water, scopolamine treated group: received scopolamine 1 mg/kg
for 15 days, two scopolamine + T. vulgaris treated groups: received scopolamine and
T. vulgaris extract 50 and 100 mg/kg body weight per day for 15 days, two intact groups:
received T. vulgaris extract 50 and 100 mg/kg body weight per day for 15 days.
Results: Administration of T. vulgaris extract signiﬁcantly restored memory and
learning impairments induced by scopolamine in the passive avoidance test and Morris
water maze test.
Conclusions: T. vulgaris extract has repairing effects on memory and behavioral dis-
orders produced by scopolamine and may have beneﬁcial effects in the treatment of
Alzheimer's disease.1. Introduction
Alzheimer's disease (AD) is an age-associated neurodegen-
erative disorder with many cognitive and neuropsychiatric
manifestations that result in progressive disability and eventual
incapacitation [1]. Pathological hallmarks of AD lead to loss of
forebrain cholinergic neurons and decrease of acetylcholine in
the brain of patients with AD appears to be a critical element
in producing dementia. The most encouraging treatment
for AD is still the using of acetylcholinesterase (AChE)
inhibitors [2].AChE inhibitors include rivastigmine, tacrine, donepezil, and
galantamine, while N-methyl-D-aspartate receptor antagonists
(memantine) have been also prescribed most recently [1]. The
drugs approved for the AD therapy act by counteracting the
acetylcholine deﬁcit, that is, they try to enhance the
acetylcholine level in the brain [3]. AChE presents some
limitations, such as their short half-lives and excessive side ef-
fects caused by the activation of peripheral cholinergic systems,
which is the most frequent and important side effect of these
drug therapies [4].
Scopolamine, a muscarinic cholinergic receptor antagonist,
serves as a useful pharmacological tool in producing a model of
partial amnesia. Muscarinic acetylcholine receptors mediate the
action of acetylcholine [5]. There is considerable evidence that
scopolamine causes oxidative stress through the interference
with acetylcholine in brain leading to cognitive impairment [6].
Brain oxidative stress was reported following the intra ven-
tricular administration of ethylcholine aziridinium, a toxicopen access article under the CC BY-NC-ND
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producing a persistent presynaptic cholinergic hypo function
with the induction of amnesia [6]. One factor that plays an
important role in the pathogenesis of AD is oxidative stress
that is an imbalance between free radicals and antioxidant
systems. Oxidative stress is characterized by an imbalance in
radical production of reactive oxygen species and antioxidative
defense, both are considered to have a major role in the
process of age-related neurodegeneration [7].
As well-known, plants have been utilized for medical treat-
ment of various diseases since ages or have been proﬁtable
sources for bioactive compounds. Plant extracts may provide a
source of new compounds including many drugs that are derived
from plant sources. Thymus vulgaris (T. vulgaris) is one of the
best-known medicinal plants of the mint family and grows
abundantly in the mountainous areas of the central part of Iran.
T. vulgaris characterized by the large scale component of free
radical scavenger essential oils such as thymol, carvacrol, 8-
terpinene, p-cymene and a-pinene. Carvacrol and thymol are
the main components of T. vulgaris [8]. Active ingredients of
T. vulgaris are useful in the treatment of convulsions,
respiratory diseases, smooth muscle spasm and bloating [9].
Meanwhile, T. vulgaris has an antispasmodic action on guinea
pig ileum by decreasing the amplitudes of the muscle
contractions during peristalsis by affecting the anticholinergic
and serotonergic pathways [9].
The hydro-alcoholic extract of T. vulgaris can modulate acute
and chronic pain in mice [10]. In this study, we investigated
whether the T. vulgaris extract could inhibit the memory
impairment induced by scopolamine through the inhibition of
AChE or decrease the oxidative stress. The restored degree of
impairment was gauged using both passive avoidance and the
Morris water maze tests with or without treatment.
2. Materials and methods
2.1. Preparation of the extract
T. vulgaris plants were purchased from medicinal herbs
sellers in Shahrekord and milled ﬁnally become a powder. A
total of 25 g powder was placed in 70% ethanol for 72 h. The
mixture was stirred several times per day. This extract was
ﬁltered and dried, then dissolved in water and stored at 4 C until
use [11].
2.2. Measurement of antioxidant activity
Sample stock solutions were diluted to ﬁnal concentrations of
10, 20, 30, 40, 50, 60, 70, 80, 90, and 100 mg/mL in methanol.
1,1-diphenyl-2-picryl-hydrazyl (DPPH) methanol solution was
added to sample solutions and allowed to react at room tem-
perature. After 15 min the absorbance values were measured at
517 nm and converted into the percentage antioxidant activity
using the following formula [12]:
Ið%Þ= 100 × Acontrol −Asample

Acontrol
2.3. Total phenolic compounds measurement
Total phenolic compounds were determined using a modiﬁed
version of the Folin–Ciocalteu method. About 0.1 mL of theextract was added to 0.5 mL of Folin–Ciocalteu phenol reagent.
The mixture was then allowed to stand for 5 min and 0.4 mL
sodium carbonate was added to the mixture. The resulting blue
complex was then measured at 680 nm. The standard curve was
plotted using 12.5, 25.0, 50.0, 62.5, 100.0, and 125.0 mg/L
solutions of gallic acid in methanol and water (60:40, v/v). The
amount of phenols was obtained based on mg/g in gallic acid
equivalent [13].
2.4. Total ﬂavonoid and ﬂavonol determination
Brieﬂy, the amount of total ﬂavonoids in the T. vulgaris
extract was determined using the colorimetric method. Solution
with 1.5 mL of methanol (60%), 1 mL of 2% aluminum chlo-
ride, and 6 mL of 5% potassium acetate was added to 1 mL of
the T. vulgaris extract. The mixture was left at room temperature
for 40 min. The absorbance of the reaction mixture was then
measured at 415 nm. The aluminum chloride colorimetric
method was employed for ﬂavonol determination, but the in-
cubation period was 150 min and the absorbance of the reaction
mixture was determined at 440 nm. Total ﬂavonoids and ﬂa-
vonols were expressed in terms of rutin equivalent (mg/g),
which is a common reference compound [14].
2.5. Animals
Male Wistar rats, weighing 150–250 g, were obtained from
Pasteur Institute (Tehran, Iran). Rats were housed in cage at
25 C with a controlled 12 h light–dark cycle. Food and water
were freely available. All experiments were executed in accor-
dance with the Guide for the Care and Use at Laboratory Ani-
mals and were approved by Research and Ethics Committee of
Medical Sciences School of Shahrekord University.
Animals were randomly divided into 6 groups with 7 rats in
each group: Control group, received distilled water for 15 days
via i.p. injection; Scopolamine (SCOP) treated group: rats
received scopolamine at a dose of 1 mg/kg for 15 days via i.p.
injection; Scopolamine + T. vulgaris (SCOP-TV) 50, 100
groups: rats received T. vulgaris extract at 50 and 100 mg
simultaneously with scopolamine at 1 mg/kg for 15 days; Intact
groups received only T. vulgaris extract at 50 and 100 mg/kg
respectively, for 15 days.
Following the behavioral tests, under deep anesthesia the
blood sample collected from heart and the brains was quickly
removed. Different parts of the brains such as hippocampus,
cortex and subcortex were separated.
2.6. Water maze test
The water maze test is also a widely accepted method for
memory test. A circular water pool was ﬁlled with milky water
kept at 22–25 C. An escape platform was submerged below the
surface of the water in position. On training trials, the rats were
placed in a pool of water and allowed to remain on the platform
for 10 s and were then returned to the home cage during the
second-trial interval. The rats that did not ﬁnd the platform
within 60 s were placed on the platform for 10 s at the end of
trial. Animals were given 4 trials daily for 4 consecutive days.
On the 15th day, rats were individually subjected to a probe trial
session by removing the platform and were allowed to swim for
120 s to search for the platform.
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The passive avoidance test is widely accepted as a simple and
rapid method for memory test. The passive avoidance response
was determined using a step-through apparatus that consisted of
a lighted compartment and a dark compartment with a grid ﬂoor.
The 2 compartments were separated by a guillotine door and
each had a grid ﬂoor through which a foot shock could be
delivered. This test was performed for each rat during the 4 days.
On the 1st and 2nd days of testing, each rat was placed on the
apparatus and left for 5 min to habituate to the apparatus. On the
3rd day, an acquisition trial was performed. On the training day,
the rat was placed in the lighted compartment, facing away from
the dark compartment and allowed to explore for 20 s. After 20 s
the guillotine door was lifted. When the rat entered the dark
compartment the guillotine door was closed, and the latency to
enter was recorded. After the door was closed, a foot shock
(1 mA, 1 s duration) was delivered through the stainless steel
rods. On the 4th day (24 h after training), the rat was returned to
the lighted compartment. After 5 s, the guillotine door was lifted.
When the rat entered the dark compartment, the guillotine door
was closed, and the step-through latency for animals was
recorded.
2.8. Assessment of antioxidant power in brain and
serum
Antioxidant power of brain or serum was determined by
measuring its ability to reduce Fe3+ to Fe2+ established as the
ferric reducing-antioxidant power (FRAP) test. The reagents
included 300 mmol/L acetate buffer solution (pH 3.6) with
16 mL acetic acid per 1 L of buffer solution, 10 mL trypyridyl-s-
triazine in 40 mmol/L HCl and 20 mmol/L FeCl3. A total of
50 mL of supernatant or serum was added to 1.5 mL of freshly
prepared reagent warmed at 37 C. After 10 min, the complex
between Fe2
+ and trypyridyl-s-triazine gives a blue color with
absorbance at 593 nm. Data were expressed as mmol/L per g of
wet tissue or mmol/L per L serum [15].
2.9. Measurement of plasma malondialdehyde (MDA)
Plasma MDA levels were estimated by high performance
liquid chromatography. A C18 column was used for separation
of the thiobarbituric acid-MDA adduct. Brieﬂy, to 100 mL
plasma or standard, 100 mL sodium dodecyl sulfate (8.1%) and
2.5 mL thiobarbituric acid (TBA)/buffer (prepared by dissolving
of 0.53% thiobarbituric acid in 20% acetic acid as adjusted to pH
3.5 with NaOH) were added. The tubes were covered with caps
and incubated at 95 C for 60 min. The reaction was stopped by
placing tubes on ice followed by centrifugation at 4 000 r/min
for 10 min to separate 2 phases. The supernatant (20 mL) was
injected into the high performance liquid chromatography
system.
2.10. MDA levels of brain
For assessment of lipid peroxidation in brain tissue, after
sacriﬁce, the animals were decapitated and the brains rapidly
removed. Brain tissues were homogenized in ice-cold Tris-HCl
buffer (50 mmol/L, pH 7.4) for 2 min at 5 000 r/min. The ho-
mogenized solution was then centrifuged for 60 min at 4 300 r/min. The optimized TBA assay was as follows: 100 mL super-
natant was treated with 10 mL butylated hydroxytoluene 0.5 mol/
L, followed by addition of 200 mL 8.1% sodium didosylesol-
phate and 1.5 mL TBA. Then samples were heated for 60 min in
boiling water bath (at 95 C). After cooling at 4 C, 3 mL
butanol-pyridine was added to the samples and centrifuged at
3 900 r/min for 10 min. Finally, an aliquot (120 mL) was directly
injected onto the high performance liquid chromatography sys-
tem [16].
2.11. Plasma nitric oxide (NO) levels
Serum samples were stored at −20 C and deproteinized by
adding ZnSO4 and NaOH solutions. After centrifuging, the su-
pernatant was recovered and diluted by glycine buffer. Cadmium
granules were rinsed 3 times with deionised distilled water and
swirled in a 5 mmol/L CuSO4 solution in glycine-NaOH buffer
for 5 min to activate. Freshly activated cadmium granules were
added to pretreated deproteinized serum. After continuous stir-
ring for 10 min, the samples were transferred to appropriately
labeled tubes for nitrite determination by Griess reaction. Griess
reagent 1 (1% sulfanilamide in 5% phosphoric acid) was added
to the sample tubes, incubated for 10 min at room temperature
and protected from light. Finally, Griess reagent 2 was dispensed
(0.1% N-naphthylethylenediamine dihydrochloride in water) to
all samples and absorbance was measured within 10 min in a
spectrophotometer with a 540 nm ﬁlter [17].
2.12. Statistical analysis
Data were expressed as mean ± SEM and processed by
commercially available software SPSS 11.0. All results were
compared using One-way ANOVA and post-hoc Tukey test. P-
value less than 0.05 was considered to be statistically signiﬁcant.
3. Results
3.1. Standardization of T. vulgaris extract
Total amount of phenolic compounds in T. vulgaris extract
was 209 mg gallic acid equivalent per 1 g dried extract. Total
amount of ﬂavonoid and ﬂavonol compounds were 21.8 mg and
10.7 mg, respectively per 1 g of dry matter.
3.2. Effect of T. vulgaris extract on DPPH free radical
scavenging
The antioxidant activity of T. vulgaris extract was assessed
on the basis of radical scavenging of the stable DPPH free
radical. T. vulgaris extract showed strong free radical scav-
enging activity against DPPH radicals, with an IC50 value of
70 mg/mL (Table 1).
3.3. Passive avoidance response
The latency time to enter the dark chamber in the acquisition
trial was signiﬁcantly longer in the rats given scopolamine, as
compared to the control group. Initial latency (T1) signiﬁcantly
reduced in Intact + 100 TV group when compared with SCOP
group (P < 0.05). The step-through latency time (T2) in the
SCOP group in the retention trial was signiﬁcantly shorter than
Figure 2. The time spent in target quadrant during the probe trial.
S5: SCOP + 50TV; S100: SCOP + 100TV group; I50: Intact + 50TV; I100:
Intact + 100TV; **: P < 0.01.
Figure 3. Plasma antioxidant levels in experimental groups.
S5: SCOP + 50TV; S100: SCOP + 100TV group; I50: Intact + 50TV; I100:
Intact + 100TV; *: P < 0.05.
Table 1
DPPH radical scavenging activity of T. vulgaris extract at different
concentrations.
Concentration (mg/mL) Inhibition (%)
10 16.89
20 19.80
30 25.80
40 33.00
50 41.74
60 54.10
70 59.60*
80 65.40
90 70.80
100 80.30
*: IC50 value (%).
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latency (T2) time of intact rats treated with T. vulgaris extract at
dose of 100 mg/kg signiﬁcantly increased compared to SCOP
rats (Figure 1).
3.4. Morris water maze swimming test
The time spent by the animal, searching for the missing
platform in target quadrant with respect to other quadrant on day
5 was noted as an index of retrieval memory. SCOP group
signiﬁcantly spent less time in the correct quadrant compared
with control group in the probe trail (P < 0.05). In the probe trial
following the last training session T. vulgaris with doses of
100 mg/kg increased the swimming time in the target quadrant
in intact group (Figure 2).
3.5. Plasma antioxidant level
Scopolamine treatment signiﬁcantly decreased the plasma
antioxidant level compared to the control group (P < 0.05).
T. vulgaris extract with doses of 50 and 100 mg/kg in intact
groups signiﬁcantly increased plasma antioxidant levels
compared with SCOP group (P < 0.05). Plasma antioxidant
levels in SCOP+50TV group signiﬁcantly higher than SCOP
group (Figure 3).Figure 1. The initial latency and step-through latency in the passive
avoidance response. :
S5: SCOP + 50TV; S100: SCOP + 100TV group; I50: Intact + 50TV; I100:
Intact + 100TV; *: P < 0.05; **: P < 0.01; SCOP vs. control,
SCOP + 50TV, SCOP + 100TV, Intact + 50TV, Intact + 100TV groups
(n = 7).3.6. Brain antioxidant levels
T. vulgaris extract signiﬁcantly increased antioxidant levels
of hippocampus, cortex and subcortex in SCOP+50TV,
SCOP+100TV groups compared with SCOP group. T. vulgaris
extract at dose of 50 mg/kg in intact groups increased antioxi-
dant levels of cortex compared with SCOP group (Figure 4).Figure 4. Brain antioxidant levels (FRAP) in experimental groups.
S5: SCOP + 50TV; S100: SCOP + 100TV group; I50: Intact + 50TV; I100:
Intact + 100TV; ***P < 0.005, **P < 0.01, *P < 0.05.
Figure 5. Brain MDA levels in experimental groups.
S5: SCOP + 50TV; S100: SCOP + 100TV group; I50: Intact + 50TV; I100:
Intact + 100TV; *P < 0.05.
Figure 6. Plasma NO levels in experimental groups.
S5: SCOP + 50TV; S100: SCOP + 100TV group; I50: Intact + 50TV; I100:
Intact + 100TV; *P < 0.05.
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Scopolamine increased MDA levels of hippocampus, cortex
and subcortex in SCOP group compared with control group but
these changes not statistical signiﬁcant. T. vulgaris extract with
dose of 50 and 100 mg/kg signiﬁcantly decreased subcortex
MDA levels in SCOP+50TV and SCOP+100TV groups.
T. vulgaris extract with dose of 100 mg/kg in intact group
signiﬁcantly decreased hippocampus MDA levels compared
with SCOP group (Figure 5).
3.8. Plasma NO levels
Scopolamine treatment nonsigniﬁcantly increased plasma
NO levels when compared with control group. T. vulgaris
extract signiﬁcantly decreased plasma NO levels in
SCOP+50TV, SCOP+100TV, Intact+50TV, Intact+100TV
groups compared with SCOP group (Figure 6).
4. Discussion
AD is a chronic neurodegenerative disease that usually starts
slowly and gets worse over time, and it is the cause of more than
50% of dementia patients developing in the population older than
60 years of age [18]. Brain aging is known to be related to decrease
in acetylcholine level, neuronal loss, increased inﬂammation, and
oxidative stress [19]. In AD patients acetylcholine levels depleted
in the brain. Centrally acting cholinergic drugs have beenreported to increase the regional cerebral blood ﬂow of
acetylcholine in the brain regions [20]. The maintaining of the
acetylcholine level in the brain is important for the cure of AD
patients. One method for this is blocking the activity of AChE,
the enzyme-degrading acetylcholine [20].
The anticholinergic drugs, like scopolamine, can disrupt
short-term or working memory in humans and animals by
blocking muscarinic receptors in these brain regions [21]. The
AChE inhibitors, which enhance the availability of
acetylcholine in the synaptic cleft, were able to reverse the
scopolamine induced deﬁcit [21]. The novel AChE inhibitors
from plant sources could be valuable alternatives in the
context of the treatment of AD. Several studies have showed
the cognition-enhancing properties of natural products and
their components using different animal models [12, 22, 23].
Thymohydroquinone exhibited the strongest AChE inhibi-
tory effect over the range of concentrations. The AChE inhibi-
tory effect exerted by carvacrol was 10 times stronger than that
exerted by its isomer thymol, although thymol and carvacrol
have a very similar structure [24]. T. vulgaris indicates
neuroprotective effects due to their small molecular size and
lipophilicity, volatile constituents and liberated volatile
aglycones from glycosides are likely to readily cross the
blood–brain barrier [25]. The previous study indicated that,
after galantamine, thymohydroquinone exhibited the strongest
AChE inhibitory effect [24].
Scopolamine also causes oxidative stress through the inter-
ference with acetylcholine in brain leading to cognitive impair-
ment [6]. Scopolamine signiﬁcantly increases AChE and MDA
levels in the cortex and hippocampus [6]. This study aimed at
investigating whether such impaired cognition due to
scopolamine administration is associated with altered oxidative
stress indices. The cognitive-enhancing activity of T. vulgaris
extract on the scopolamine induced memory impairments in rat
was investigated using passive avoidance test, Morris water
maze test and biochemical assessments.
The passive avoidance task is one of the most frequently
employed methods for evaluating memory enhancing effects,
in vivo. T. vulgaris extract signiﬁcantly reversed the shorter step-
through latency induced by scopolamine. In probe trail session
in Morris Water Maze test the scopolamine-induced reduction in
swimming times within the platform quadrant was signiﬁcantly
ameliorated by T. vulgaris extract. The T. vulgaris compounds
such as thymol, carvacrol and different quinines have anti-
inﬂammatory effects in vitro [26]. The strong AChE inhibitory
effect was observed with the compounds that have been
previously identiﬁed as strong antioxidants [27].
Our results indicated that scopolamine increased brain MDA
levels. T. vulgaris extract decreased brain MDA levels in
experimental groups. MDA is one of the major aldehydes
formed after breakdown of lipid hydroperoxides. Therefore, it is
considered as a good biomarker of the involvement of free
radical damage in pathologies associated with oxidative stress
[28]. The brain is considered to be more susceptible to
peroxidative damage than other tissues due to the high content
of their polyunsaturated lipid-rich neural parenchyma, high ox-
ygen utilization and low antioxidative enzymes. Furthermore,
previous studies indicated that oxidative stress is one of the
earliest events in pathogenesis of memory impairment [29].
Oxidative stress was produced by free radicals, i.e., reactive
oxygen species generated by oxygen and nitrogen-based mole-
cules that have unpaired electrons [29].
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arginine to l-citrulline by NO synthase. NO when combined with
superoxide generates a potent radical, peroxynitrite, which ac-
tivates lipid peroxidation [30]. Our results showed that
scopolamine signiﬁcantly increased serum NO levels.
T. vulgaris extract signiﬁcantly decreased serum NO levels in
experimental groups. The other studies conﬁrmed our studies,
thymol and carvacrol alleviated cognitive impairments caused
by increased Ab levels in rats [31].
Our results suggested that the anti-amnesic effect of
T. vulgaris extract on scopolamine-induced memory impairment
may be related to the antioxidant activity of extract or mediation
of the cholinergic nervous system [32–34]. Therefore, other plants
which have antioxidant activity [35–39] might reduce amnesia.
Conﬂict of interest statement
We declare that we have no conﬂict of interest.
Acknowledgments
This article was derived from MD thesis of Samira Rahnama
and the research was supported by Research and Technology
Deputy of Shahrekord University of Medical Sciences with
grant number of 1756.
References
[1] Figueiro´ M, Ilha J, Linck VM, Herrmann AP, Nardin P,
Menezes CB, et al. The Amazonian herbal marapuama attenuates
cognitive impairment and neuroglial degeneration in a mouse
Alzheimer model. Phytomedicine 2011; 18(4): 327-33.
[2] Chiang VS. MicroRNAs as potential regulators of docosahexae-
noic acid beneﬁts in Alzheimer's disease. Nutr Neurosci 2015;
http://dx.doi.org/10.1179/1476830515Y.
[3] Schliebs R, Arendt T. The cholinergic system in aging and
neuronal degeneration. Behav Brain Res 2011; 221(2): 555-63.
[4] Haense C, Kalbe E, Herholz K, Hohmann C, Neumaier B, Krais R,
et al. Cholinergic system function and cognition in mild cognitive
impairment. Neurobiol Aging 2012; 33(5): 867-77.
[5] Rezvani AH, Cauley M, Sexton H, Xiao Y, Brown ML, Paige MA,
et al. Sazetidine-A, a selective a4b2 nicotinic acetylcholine re-
ceptor ligand: effects on dizocilpine and scopolamine-induced
attentional impairments in female Sprague-Dawley rats. Psycho-
pharmacology (Berl) 2011; 215(4): 621-30.
[6] Rahnama S, Rabiei Z, Alibabaei Z, Mokhtari S, Raﬁeian-kopaei M,
Deris F. Anti-amnesic activity of Citrus aurantium ﬂowers extract
against scopolamine-induced memory impairments in rats. Neurol
Sci 2015; 36(4): 553-60.
[7] Christen Y. Oxidative stress and Alzheimer disease. Am J Clin
Nutr 2000; 71(2): 621S-9S.
[8] Akkol EK, Avci G, Ku¨çu¨kkurt I, Keles¸ H, Tamer U, Ince S, et al.
Cholesterol-reducer, antioxidant and liver protective effects of
Thymbra spicata L. var. spicata. J Ethnopharmacol 2009; 126(2):
314-9.
[9] Babaei M, Abarghoei ME, Ansari R, Vafaei AA, Taherian AA,
Akhavan MM, et al. Antispasmodic effect of hydroalcoholic
extract of Thymus vulgaris on the guinea-pig ileum. Nat Prod Res
2008; 22(13): 1143-50.
[10] Taherian AA, Rashidi Pour A, Areﬁ M, Vafaei A, Abarghoei ME,
Sadeghi H, et al. Assessment of hydroalcoholic extract of Thymus
vulgaris on neurogenic and inﬂammatory pain in mice. J Babol
Univ Med Sci 2005; 7: 24-9.
[11] Naseri MKG. Effect of Zataria multiﬂora Boiss leaf hydroalcoholic
extract on rat ileum. J Kermanshah Univ Med Sci 2003; 7(3): 18-
26.[12] Rabiei Z, Raﬁeian-Kopaei M, Heidarian E, Saghaei E, Mokhtari S.
Effects of Zizyphus jujube extract on memory and learning
impairment induced by bilateral electric lesions of the nucleus
Basalis of Meynert in rat. Neurochem Res 2014; 39(2): 353-60.
[13] Rabiei Z, Raﬁeian-Kopaei M. Neuroprotective effect of pretreat-
ment with Lavandula ofﬁcinalis ethanolic extract on blood-brain
barrier permeability in a rat stroke model. Asian Pac J Trop Med
2014; 7(Suppl 1): S421-6.
[14] Rabiei Z, Raﬁeian-Kopaei M, Mokhtari S, Shahrani M. Effect of
dietary ethanolic extract of Lavandula ofﬁcinalis on serum lipids
proﬁle in rats. Iran J Pharm Res 2014; 13(4): 1295-301.
[15] Alibabaei Z, Rabiei Z, Rahnama S, Mokhtari S, Raﬁeian-kopaei M.
Matricaria chamomilla extract demonstrates antioxidant properties
against elevated rat brain oxidative status induced by amnestic dose
of scopolamine. Biomed Aging Pathol 2014; 4: 355-60.
[16] Takahashi Y, Soejima Y, Kumagai A, Watanabe M, Uozaki H,
Fukusato T. Inhibitory effects of Japanese herbal medicines sho-
saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in
mice. PloS One 2014; 9(1): e87279.
[17] Tatsch E, Bochi GV, Pereira Rda S, Kober H, Agertt VA, de
Campos MM, et al. A simple and inexpensive automated technique
for measurement of serum nitrite/nitrate. Clin Biochem 2011;
44(4): 348-50.
[18] Parihar MS, Hemnani T. Alzheimer's disease pathogenesis and
therapeutic interventions. J Clin Neurosci 2004; 11(5): 456-67.
[19] Harman D. Alzheimer's disease pathogenesis: role of aging. Ann N
Y Acad Sci 2006; 1067: 454-60.
[20] Ellis JM. Cholinesterase inhibitors in the treatment of dementia.
J Am Osteopath Assoc 2005; 105(3): 145-58.
[21] Baxter MG, Bucci DJ, Gorman LK, Wiley RG, Gallagher M. Se-
lective immunotoxic lesions of basal forebrain cholinergic cells:
effects on learning and memory in rats. Behav Neurosci 1995;
109(4): 714-22.
[22] Rabiei Z, Raﬁeian-Kopaei M, Mokhtari S, Alibabaei Z,
Shahrani M. The effect of pretreatment with different doses of
Lavandula ofﬁcinalis ethanolic extract on memory, learning and
nociception. Biomed Aging Pathol 2014; 4(1): 71-6.
[23] Rabiei Z, Hojjati M, Raﬁeian-Kopaeia M, Alibabaei Z. Effect of
Cyperus rotundus tubers ethanolic extract on learning and memory
in animal model of Alzheimer. Biomed Aging Pathol 2013; 3(4):
185-91.
[24] Jukic M, Politeo O, Maksimovic M, Milos M, Milos M. In vitro
acetylcholinesterase inhibitory properties of thymol, carvacrol and
their derivatives thymoquinone and thymohydroquinone. Phytother
Res 2007; 21(3): 259-61.
[25] Savelev SU, Okello EJ, Perry EK. Butyryl- and acetyl-
cholinesterase inhibitory activities in essential oils of Salvia
species and their constituents. Phytother Res 2004; 18(4): 315-
24.
[26] Landa P, Kokoska L, Pribylova M, Vanek T, Marsik P. In vitro
anti-inﬂammatory activity of carvacrol: inhibitory effect on COX-2
catalyzed prostaglandin E2 biosynthesis. Arch Pharm Res 2009;
32(1): 75-8.
[27] Kruk I, Michalska T, Lichszteld K, Kładna A, Aboul-Enein HY.
The effect of thymol and its derivatives on reactions generating
reactive oxygen species. Chemosphere 2000; 41(7): 1059-64.
[28] Zelzer S, Oberreither R, Bernecker C, Stelzer I, Truschnig-
Wilders M, Fauler G. Measurement of total and free malondial-
dehyde by gas-chromatography mass spectrometry–comparison
with high-performance liquid chromatography methology. Free
Radic Res 2013; 47(8): 651-6.
[29] Nasri H, Raﬁeian-Kopaei M. Medicinal plants and antioxidants:
why they are not always beneﬁcial? Iran J Public Health 2014;
43(2): 255-7.
[30] Schoﬁeld ZV, Woodruff TM, Halai R, Wu MC, Cooper MA.
Neutrophils–a key component of ischemia-reperfusion injury.
Shock 2013; 40(6): 463-70.
[31] Azizi Z, Ebrahimi S, Saadatfar E, Kamalinejad M, Majlessi N.
Cognitive-enhancing activity of thymol and carvacrol in two rat
models of dementia. Behav Pharmacol 2012; 23(3): 241-9.
Zahra Rabiei et al./Asian Pac J Trop Biomed 2015; 5(10): 845–851 851[32] Karamati SA, Hassanzadazar H, Bahmani M, Raﬁeian-Kopaei M.
Herbal and chemical drugs effective on malaria. Asian Pac J Trop
Dis 2014; 4(Suppl 2): S599-601.
[33] Bahmani M, Raﬁeian-Kopaei M, Jeloudari M, Eftekhari Z,
Delfan B, Zargaran A, et al. A review of the health effects and uses
of drugs of plant licorice (Glycyrrhiza glabra L.) in Iran. Asian Pac
J Trop Dis 2014; 4(Suppl 2): S847-9.
[34] Delfan B, Bahmani M, Raﬁeian-Kopaei M, Delfan M, Saki K.
A review study on ethnobotanical study of medicinal plants used in
relief of toothache in Lorestan Province, Iran. Asian Pac J Trop Dis
2014; 4(Suppl 2): S879-84.
[35] Raﬁeian-Kopaei M, Shahinfard N, Rouhi-Boroujeni H,
Gharipour M, Darvishzadeh-Boroujeni P. Effects of Ferulago
angulata extract on serum lipids and lipid peroxidation. Evid Based
Complement Alternat Med 2014; 2014: 680856; http://dx.doi.org/
10.1155/2014/680856 [Epub 2014 Feb 24].[36] Baradaran A, Nasri H, Nematbakhsh M, Raﬁeian-Kopaei M.
Antioxidant activity and preventive effect of aqueous leaf extract
of Aloe Vera on gentamicin-induced nephrotoxicity in male
Wistar rats. Clin Ter 2014; 165(1): 7-11; http://dx.doi.org/10.7471/
CT.2014.1653.
[37] Raﬁeian-Kopaei M, Baradaran A, Raﬁeian M. Oxidative stress and
the paradoxical effects of antioxidants. J Res Med Sci 2013 Jul;
18(7): 629; http://dx.doi.org/10.12860/jnp.2014.23.
[38] Setorki M, Raﬁeian-Kopaei M, Merikhi A, Heidarian E,
Shahinfard N, Ansari R, et al. Suppressive impact of anethum
graveolens consumption on biochemical risk factors of athero-
sclerosis in hypercholesterolemic rabbits. Int J Prev Med 2013
Aug; 4(8): 889-95.
[39] Nasri H, Raﬁeian-Kopaei M. Protective effects of herbal antioxi-
dants on diabetic kidney disease. J Res Med Sci 2014 Jan; 19(1):
82-3.
